BCI
DXCM icon

Brinker Capital Investments’s DexCom DXCM Stock Holding History

Brinker Capital Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
29,541
+2,456
+9% +$164K 0.02% 803
2026
Q1 		$1.7M Buy
27,085
+10,344
+62% +$720K 0.01% 838
2025
Q4 		$1.11M Sell
16,741
-7,265
-30% -$470K 0.01% 1189
2025
Q3 		$1.62M Sell
24,006
-3,219
-12% -$255K 0.01% 956
2025
Q2 		$2.38M Sell
27,225
-2,186
-7% -$171K 0.02% 693
2025
Q1 		$2.01M Buy
29,411
+1,230
+4% +$100K 0.02% 706
2024
Q4 		$2.19M Buy
28,181
+24,624
+692% +$1.82M 0.02% 649
2024
Q3 		$238K Sell
3,557
-8,634
-71% -$709K ﹤0.01% 1631
2024
Q2 		$1.38M Buy
12,191
+2,320
+24% +$293K 0.01% 827
2024
Q1 		$1.37M Buy
9,871
+2,388
+32% +$300K 0.01% 845
2023
Q4 		$970K Buy
7,483
+247
+3% +$25.2K 0.01% 951
2023
Q3 		$675K Sell
7,236
-1,082
-13% -$122K 0.01% 1084
2023
Q2 		$726K Buy
8,318
+2,944
+55% +$356K 0.01% 1071
2023
Q1 		$624K Buy
5,374
+2,017
+60% +$226K 0.01% 1064
2022
Q4 		$380K Sell
3,357
-141
-4% -$15.5K 0.01% 1070
2022
Q3 		$282K Buy
3,498
+736
+27% +$62.3K 0.01% 1144
2022
Q2 		$206K Sell
2,762
-1,030
-27% -$94K ﹤0.01% 1297
2022
Q1 		$485K Sell
3,792
-60
-2% -$6.56K 0.01% 1059
2021
Q4 		$517K Buy
3,852
+496
+15% +$71.3K 0.01% 1040
2021
Q3 		$358K Hold
3,356
– – 0.01% 1080
2021
Q2 		$358K Buy
3,356
+72
+2% +$6.91K ﹤0.01% 1134
2021
Q1 		$295K Buy
+3,284
New +$308K ﹤0.01% 1055
2020
Q4 		– Sell
-2,616
Closed -$270K – 1057
2020
Q3 		$270K Buy
+2,616
New +$273K ﹤0.01% 1038
2016
Q4 		– Sell
-8
Closed – – 524
2016
Q3 		$0 Buy
+8
New +$178 ﹤0.01% 524
2016
Q1 		– Sell
-28
Closed -$1K – 473
2015
Q4 		$1K Buy
28
+4
+17% +$83 ﹤0.01% 500
2015
Q3 		$1K Buy
+24
New +$535 ﹤0.01% 428

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brinker Capital Investments's DXCM Position: Q2 2026 in Review

Brinker Capital Investments increased its DexCom (DXCM) stake by 9.1% in Q2 2026, buying an estimated $164K and bringing the position to 29,541 shares worth $1.99M. The position accounts for 0.02% of the portfolio, ranked #803.

Brinker Capital Investments first reported a position in DXCM in Q3 2015 and has held it in 26 quarters since. The position peaked at $2.38M in Q2 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Brinker Capital Investments held 29,541 shares of DexCom worth $1.99M as of Q2 2026.
  • Brinker Capital Investments bought 2,456 DexCom shares in Q2 2026, an estimated $164K.
  • DexCom made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #803 holding.
  • Brinker Capital Investments first reported a position in DexCom in Q3 2015 and has held it in 26 quarters since.
  • Brinker Capital Investments's DexCom position peaked at $2.38M in Q2 2025.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.